Clinical and Economic Burden of Depression/Anxiety in Chronic Obstructive Pulmonary Disease Patients within a Managed Care Population

REFERENCES

• Foster TS, Miller JD, Marton JP, Caloyeras JP, Russell MW, Menzin J. Assessment of the economic burden of COPD in the U.S.: A review and synthesis of the literature. COPD 2006; 3(4):211–218.
   PubMedGoogle Scholar
• Goetzel RZ, Hawkins K, Ozminkowski RJ, Wang S. The health and productivity cost burden of the “top 10” physical and mental health conditions affecting six large U.S. employers in 1999. J Occup Environ Med 2003; 45(1):5–14.
   PubMed Web of Science ®Google Scholar
• Mannino DM, Braman S. The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007; 4(7):502–506.
   PubMedGoogle Scholar
• Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance—United States, 1971–2000. MMWR Surveill Summ. 2002; 51(6):1–16.
   Google Scholar
• Schneider KM, O'Donnell BE, Dean D. Prevalence of multiple chronic conditions in the United States’ Medicare population. Health Qual Life Outcomes 2009; 7:82.
   PubMed Web of Science ®Google Scholar
• Maurer J, Rebbapragada V, Borson S, Goldstein K, Kunik ME, Yohannes AM, Hanania NA; ACCP Workshop Panel on Anxiety and Depression in COPD. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest 2008; 134(4 Suppl):43S–56S.
   PubMed Web of Science ®Google Scholar
• Schane RE, Walter LC, Dinno A, Covinsky KE, Woodruff PG. Prevalence and risk factors for depressive symptoms in persons with chronic obstructive pulmonary disease. J Gen Intern Med. 2008; 23(11):1757–1762. Erratum in: J Gen Intern Med 2008; 23(11):1930.
   PubMed Web of Science ®Google Scholar
• Egede LE. Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability. Gen Hosp Psych 2007; 29(5):409–416.
   PubMed Web of Science ®Google Scholar
• Stein MB, Cox BJ, Afifi TO, Belik SL, Sareen J. Does co-morbid depressive illness magnify the impact of chronic physical illness? A population-based perspective. Psychol Med 2006; 36(5):587–596.
   PubMed Web of Science ®Google Scholar
• McLaughlin T, Geissler EC, Wan GJ. Co-morbidities and associated treatment charges in patients with anxiety disorders. Pharmacotherapy 2003; 23(10):1251–1256.
   PubMed Web of Science ®Google Scholar
• Lewis KE, Annandale JA, Sykes RN, Hurlin C, Owen C, Harrison NK. Prevalence of anxiety and depression in patients with severe COPD: similar high levels with and without LTOT. COPD 2007; 4(4):305–312.
   PubMedGoogle Scholar
• IMS LifeLink® Health Plan Claims Database, PharMetrics, Inc., a unit of IMS, Watertown, MA. Copyright 2009, All Rights Reserved.
   Google Scholar
• Arne M, Janson C, Janson S, Boman G, Lindqvist U, Berne C, Emtner M. Physical activity and quality of life in subjects with chronic disease: chronic obstructive pulmonary disease compared with rheumatoid arthritis and diabetes mellitus. Scand J Prim Health Care 2009; 27(3):141–147.
   PubMed Web of Science ®Google Scholar
• Cully JA, Graham DP, Stanley MA, Ferguson CJ, Sharafkhaneh A, Souchek J, Kunik ME. Quality of life in patients with chronic obstructive pulmonary disease and co-morbid anxiety or depression. Psychosomatics 2006; 47(4):312–319.
   PubMed Web of Science ®Google Scholar
• FitzGerald JM, Haddon JM, Bradly-Kennedy C, Kuramoto L, Ford GT; RUSIC Study Group. Resource use study in COPD (RUSIC): a prospective study to quantify the effects of COPD exacerbations on health care resource use among COPD patients. Can Respir J 2007; 14(3):145–152.
   PubMed Web of Science ®Google Scholar
• Katon W, Lin EH, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psych 2007; 29(2):147–155.
   PubMed Web of Science ®Google Scholar
• Lyness JM, Niculescu A, Tu X, Reynolds CF 3rd, Caine ED. The relationship of medical co-morbidity and depression in older, primary care patients. Psychosomatics 2006; 47(5):435–439.
   PubMed Web of Science ®Google Scholar
• Fan VS, Ramsey SD, Giardino ND, Make BJ, Emery CF, Diaz PT, Benditt JO, Mosenifar Z, McKenna R Jr, Curtis JL, Fishman AP, Martinez FJ; National Emphysema Treatment Trial (NETT) Research Group. Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med 2007; 167(21):2345–2353.
   PubMed Web of Science ®Google Scholar
• Gudmundsson G, Gislason T, Janson C, Lindberg E, Suppli Ulrik C, Brøndum E, Nieminen MM, Aine T, Hallin R, Bakke P. Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countries. Respir Med 2006; 100(1):87–93.
   PubMed Web of Science ®Google Scholar
• Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 2007; 167(1):60–67.
   PubMed Web of Science ®Google Scholar
• Hynninen MJ, Pallesen S, Nordhus IH. Factors affecting health status in COPD patients with co-morbid anxiety or depression. Int J Chron Obstruct Pulmon Dis 2007; 2(3):323–328.
   PubMedGoogle Scholar
• Felker B, Katon W, Hedrick SC, Rasmussen J, McKnight K, McDonnell MB, Fihn SD. The association between depressive symptoms and health status in patients with chronic pulmonary disease. Gen Hosp Psych 2001; 23(2):56–61.
   PubMed Web of Science ®Google Scholar
• Carrasco-Garrido P, de Miguel-Díez J, Rejas-Gutierrez J, Martín-Centeno A, Gobartt-Vázquez E, Hernandez-Barrera V, de Miguel AG, Jimenez-Garcia R. Characteristics of chronic obstructive pulmonary disease in Spain from a gender perspective. BMC Pulm Med 2009; 9:2.
   PubMedGoogle Scholar
• Cao Z, Ong KC, Eng P, Tan WC, Ng TP. Frequent hospital readmissions for acute exacerbation of COPD and their associated factors. Respirology 2006; 11(2):188–195.
   PubMed Web of Science ®Google Scholar
• Coultas DB, Edwards DW, Barnett B, Wludyka P. Predictors of depressive symptoms in patients with COPD and health impact. COPD 2007; 4(1):23–28.
   PubMedGoogle Scholar
• Lin PJ, Shaya FT, Scharf SM. Economic implications of co-morbid conditions among Medicaid beneficiaries with COPD. Respir Med 2010; 104(5):697–704.
   PubMed Web of Science ®Google Scholar
• Xu W, Collet JP, Shapiro S, Lin Y, Yang T, Platt RW, Wang C, Bourbeau J. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med 2008; 178:913–920.
   PubMed Web of Science ®Google Scholar
• Mapel DW, McMillan GP, Frost FJ, Hurley JS, Picchi MA, Lydick E, Spencer MD. Predicting the costs of managing patients with chronic obstructive pulmonary disease. Respir Med 2005; 99:1325–1333.
   PubMed Web of Science ®Google Scholar
• Eaddy M, Shah M, Lunacsek O, Stanford R. The burden of illness of hypertension and co-morbid diabetes. Curr Med Res Opin 2008; 24(9):2501–2507.
   PubMed Web of Science ®Google Scholar
• Katon W, Cantrell CR, Sokol MC, Chiao E, Gdovin JM. Impact of antidepressant drug adherence on co-morbid medication use and resource utilization. Arch Intern Med 2005; 165:2497–2503.
   PubMed Web of Science ®Google Scholar
• Dalal AA, Shah M, D'Souza AO, Mapel DW. COPD-related healthcare utilization and costs after discharge from a hospitalization or emergency department visit on a regimen of fluticasone propionate-salmeterol combination versus other maintenance therapies. Am J Manage Care 2011 Mar 1; 17(3):e55–65. [epub ahead of print]
   PubMed Web of Science ®Google Scholar